TNFα inhibitors reduce bone loss in rheumatoid arthritis independent of clinical response by reducing osteoclast precursors and IL-20
<p><strong>Objectives</strong></p> <p>About half of RA patients treated with TNFα inhibitors either do not respond or lose their initial therapeutic response over time. The clinical response is measured by reduction in DAS28, which primarily reflects inflammation. Howev...
Váldodahkkit: | Al-Bogami, M, Bystrom, J, Clanchy, F, Taher, TE, Mangat, P, Williams, RO, Jawad, AS, Mageed, RA |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
Oxford University Press
2020
|
Geahča maid
-
Response to treatment with TNFα inhibitors in rheumatoid arthritis is associated with high levels of GM-CSF and GM-CSF(+) T lymphocytes
Dahkki: Bystrom, J, et al.
Almmustuhtton: (2017) -
TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases
Dahkki: Bystrom, J, et al.
Almmustuhtton: (2016) -
Disease status in human and experimental arthritis, and response to TNF blockade, is associated with MHC class II invariant chain (CD74) isoform expression
Dahkki: Clanchy, FIL, et al.
Almmustuhtton: (2022) -
TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis
Dahkki: Clanchy, FIL, et al.
Almmustuhtton: (2021) -
Inflammatory disease status and response to TNF blockade are associated with mechanisms of endotoxin tolerance
Dahkki: Taylor, PC, et al.
Almmustuhtton: (2024)